Thomas Joseph Knightly, MD
Psychiatry · Stamford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Offices
- 2
Offices
2 locations · Evolve Brain Health LLC · 6 clinicians in this group
Looking this up.
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Knightly’s office at (203) 504-9758 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A171719 · Current
Licensed to practise in California · since 2021 · expires 2027-02-28 · Lewis Katz School of Medicine at Temple University.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
$68,248
Medicare paid this office $68,248 for 25 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Treatment using magnetic field to stimulate nerve cells in brain, subsequent delivery and management | 12 | $56,923 | $173 |
| Psychiatric diagnostic evaluation with medical services | 14 | $2,333 | $156 |
| Psychotherapy with evaluation and management visit, 1 hour | 11 | $1,283 | $99 |
Who their Medicare patients are
25 Original Medicare patients in 2024. Average age 65 · Also on Medicaid 44% · Health risk score 1.23. At or below the middle of the specialty; the typical psychiatry clinician is at 1.35.
Conditions among them: Depression 75% · High blood pressure 44%.
The office billed $269,299, Medicare allowed $85,951 and paid $68,248; for 435 services of 9 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Medicaid work
$14,379 in 2024
Medicaid paid $14,379 for 186 billed services this clinician did in 2024, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Therapeutic repetitive transcranial magnetic stimulation (TMS) treatment; subsequent delivery and management, per session | 186 | $14,379 |
| 2024 | 186 | 1 | 12 | $14,379 |
Money from drug and device companies
$2,505 in 2025
| 2025 | 14 | 88 | None | $2,505 |
| 2024 | 3 | 6 | None | $197 |
| 2023 | 1 | 2 | None | $49 |
| 2022 | 1 | 1 | $3,000 | $3,000 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Janssen Pharmaceuticals | Spravato | $785 | 16 payments
|
| Abbvie | Vraylar | $427 | 18 payments
|
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Caplyta | $399 | 14 payments
|
| Otsuka America Pharmaceutical | Rexulti | $121 | 5 payments
|
| Teva Pharmaceuticals USA | Austedo Xr | $114 | 5 payments
|
| Corium | Azstarys | $107 | 6 payments
|
See all 88 published payments
| Janssen Pharmaceuticals | Meals · 2025-12-23 | Spravato | $60 |
| Abbvie | Meals · 2025-12-22 | Vraylar | $22 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-12-18 | Caplyta | $22 |
| Vanda Pharmaceuticals | Meals · 2025-12-17 | Fanapt | $36 |
| Abbvie | Meals · 2025-12-04 | Vraylar | $16 |
| Vanda Pharmaceuticals | Meals · 2025-11-26 | Fanapt | $22 |
| Janssen Pharmaceuticals | Meals · 2025-11-24 | Spravato | $44 |
| Otsuka America Pharmaceutical | Meals · 2025-11-21 | Rexulti | $28 |
| Corium | Meals · 2025-11-20 | Azstarys | $31 |
| Abbvie | Meals · 2025-11-19 | Vraylar | $29 |
| Supernus Pharmaceuticals | Meals · 2025-11-13 | Qelbree | $20 |
| Abbvie | Meals · 2025-11-05 | Vraylar | $11 |
| Neurocrine BioSciences | Meals · 2025-11-05 | Ingrezza | $24 |
| Vanda Pharmaceuticals | Meals · 2025-10-30 | Fanapt | $14 |
| Teva Pharmaceuticals USA | Meals · 2025-10-27 | Austedo Xr | $30 |
| Otsuka America Pharmaceutical | Meals · 2025-10-24 | Rexulti | $17 |
| Abbvie | Meals · 2025-10-22 | Vraylar | $17 |
| Abbvie | Meals · 2025-10-20 | Vraylar | $10 |
| Supernus Pharmaceuticals | Meals · 2025-10-08 | Qelbree | $26 |
| Janssen Pharmaceuticals | Meals · 2025-09-30 | Spravato | $21 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-09-27 | Caplyta | $23 |
| Otsuka America Pharmaceutical | Meals · 2025-09-25 | Rexulti | $32 |
| Teva Pharmaceuticals USA | Meals · 2025-09-22 | Austedo Xr | $17 |
| Supernus Pharmaceuticals | Meals · 2025-09-20 | Qelbree | $31 |
| Neurocrine BioSciences | Meals · 2025-09-17 | Ingrezza | $22 |
| Janssen Pharmaceuticals | Meals · 2025-09-15 | Spravato | $37 |
| Abbvie | Meals · 2025-09-11 | Vraylar | $16 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-09-09 | Caplyta | $23 |
| Tris Pharma | Meals · 2025-09-04 | Dyanavel Xr | $17 |
| Otsuka America Pharmaceutical | Meals · 2025-08-28 | Rexulti | $20 |
| Tris Pharma | Meals · 2025-08-21 | Dyanavel Xr | $17 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-08-20 | Caplyta | $20 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-08-15 | Trintellix | $25 |
| Abbvie | Meals · 2025-08-14 | Vraylar | $21 |
| Corium | Meals · 2025-08-12 | Azstarys | $3 |
| Corium | Meals · 2025-08-11 | Azstarys | $12 |
| Neurocrine BioSciences | Meals · 2025-08-11 | Ingrezza | $19 |
| Janssen Pharmaceuticals | Meals · 2025-08-06 | Spravato | $27 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-07-29 | Caplyta | $26 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-07-29 | Caplyta | $2 |
| Corium | Meals · 2025-07-28 | Azstarys | $22 |
| Abbvie | Meals · 2025-07-25 | Vraylar | $34 |
| Alkermes | Meals · 2025-07-23 | Aristada | $24 |
| Abbvie | Meals · 2025-07-21 | Vraylar | $19 |
| Abbvie | Meals · 2025-07-21 | Vraylar | $0 |
| Abbvie | Meals · 2025-07-15 | Vraylar | $15 |
| Teva Pharmaceuticals USA | Meals · 2025-06-27 | Uzedy | $20 |
| Corium | Meals · 2025-06-26 | Azstarys | $21 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-06-23 | Caplyta | $15 |
| Neurocrine BioSciences | Meals · 2025-06-19 | Ingrezza | $15 |
| Otsuka America Pharmaceutical | Meals · 2025-06-18 | Rexulti | $24 |
| Abbvie | Meals · 2025-06-16 | Vraylar | $24 |
| Janssen Pharmaceuticals | Meals · 2025-06-12 | Spravato | $19 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-06-11 | Cobenfy | $31 |
| Alkermes | Meals · 2025-06-11 | Aristada | $26 |
| Teva Pharmaceuticals USA | Meals · 2025-06-09 | Austedo Xr | $26 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-06-05 | Caplyta | $18 |
| Janssen Pharmaceuticals | Meals · 2025-06-04 | Spravato | $41 |
| Abbvie | Meals · 2025-06-02 | Vraylar | $13 |
| Corium | Meals · 2025-05-28 | Azstarys | $19 |
| Abbvie | Meals · 2025-05-21 | Vraylar | $23 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-05-20 | Cobenfy | $24 |
| Neurocrine BioSciences | Meals · 2025-05-19 | Ingrezza | $18 |
| Abbvie | Meals · 2025-05-12 | Vraylar | $24 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-05-12 | Caplyta | $15 |
| Tris Pharma | Meals · 2025-05-08 | Dyanavel Xr | $16 |
| Teva Pharmaceuticals USA | Meals · 2025-05-06 | Austedo Xr | $21 |
| Alkermes | Meals · 2025-05-02 | Aristada | $30 |
| Janssen Pharmaceuticals | Meals · 2025-05-01 | Spravato | $35 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-04-24 | Caplyta | $20 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-04-23 | Trintellix | $26 |
| Janssen Pharmaceuticals | Meals · 2025-04-22 | Spravato | $125 |
| Janssen Pharmaceuticals | Meals · 2025-04-08 | Spravato | $42 |
| Janssen Pharmaceuticals | Meals · 2025-04-02 | Spravato | $30 |
| Janssen Pharmaceuticals | Meals · 2025-03-27 | Spravato | $29 |
| Abbvie | Meals · 2025-03-27 | Vraylar | $7 |
| Axsome Therapeutics | Meals · 2025-03-27 | Auvelity | $22 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-03-26 | Caplyta | $23 |
| Janssen Pharmaceuticals | Meals · 2025-03-21 | Spravato | $23 |
| Janssen Pharmaceuticals | Meals · 2025-03-21 | Spravato | $20 |
| Janssen Pharmaceuticals | Meals · 2025-03-20 | Spravato | $149 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-03-19 | Trintellix | $22 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-03-06 | Caplyta | $31 |
| Abbvie | Meals · 2025-03-05 | Vraylar | $125 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-02-20 | Caplyta | $127 |
| Janssen Pharmaceuticals | Meals · 2025-02-03 | Spravato | $84 |
| ITI Inc. (d/b/a Intra-Cellular Therapies Inc.) | Meals · 2025-02-03 | Caplyta | $34 |
| Tris Pharma | Meals · 2025-01-21 | None | $24 |
See earlier years (2024, 2023, 2022)
2024: $197
| Janssen Pharmaceuticals | Spravato | $151 | 4 payments
|
| Tris Pharma | None | $24 | 1 payment
|
| Teva Pharmaceuticals USA | Uzedy | $22 | 1 payment
|
2023: $49
| Brainsway USA | None | $49 | 1 payment
|
2022: $3,000
| Brainsway USA | Brainsway Deep Tms | $3,000 | 1 payment
|
Professional record
- NPI
- 1447771282
- Licence
- CA A171719, CT 71157California A171719: Current · expires 2027-02-28
- Trained
- Temple University School of Medicine, 2017
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Psychiatry (2084P0800X)
- Mailing address
- 1055 Summer St Ste 2, Stamford, CT, 06905
- NPI first listed
- 2017-07-01
- NPI last updated
- 2024-09-30
- NPI record certified
- 2024-09-30
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr, Stanford, CA, 94305